Adherence to treatment: global challenge, tangible solutions

Significant problems with adherence persist across geographies and therapy areas, leading to non-optimal care and delays in recovery1.  Aside from continuous progress in healthcare technologies and the regular launch of new medicines every year, according to the WHO, the most effective intervention to improve the health of the overall population is to increase adherence to treatments2.  

Adherence has traditionally been framed as a problem of patient understanding, and even memory (as patients are thought to simply “forget” their treatment).  But what if this belief ignores the real issues and reinforces misconceptions? Approximately 25% of patients after being discharged from hospital stop some of their treatment within the first week.  This signals that the problem isn’t simply memory but is rooted in deeper behavioral and societal factors3.  

The a:care Congress 2022 explored: 

  • The pervasive myths that hide the true drivers of non-adherence 
  • How to shift the paradigm and treat the person, not just the disease 
  • How patients understand adherence, and how their insights can be used in clinical practice 

The Congress combined global sessions with local sessions that looked at specific local drivers of non-adherence and discuss tailored solutions specific to this region.

About the event

Program

Businessman writing on white board in meeting

An exciting and innovative program 

The congress addressed the common misconceptions with regards to adherence and took a deeper look at the underlying drivers behind non-adherence. Through a two-day agenda of presentations and panel discussions the a:care congress equiped you with the tools to address non-adherence through theory-driven, evidence-based behavioral interventions. 

Faculty members

Senior doctor and colleagues meeting in conference room

A diverse faculty of behavioral scientists, clinicians and patients

The congress featured sessions from international clinical experts across multiple therapy areas. The congress featured patient voice sessions to hear from individuals who struggled with adherence and can provide a first-person perspective on the specific challenges they faced.  

References

1. Jose J, Bond C. Medication Adherence: still a problem. Int J Pharm Practice. 2021;29(2):93-95. doi:10.1093/ijpp/riaa019 

2. Brown MT, Bussell JK. Medication adherence: WHO cares?. Mayo Clin Proc. 2011;86(4):304-314. doi:10.4065/mcp.2010.0575 

3. Fallis BA, Dhalla IA, Klemensberg J, Bell CM. Primary Medication Non-Adherence after Discharge from a General Internal Medicine Service. PLOS ONE. 2013;8(5):e61735. https://doi.org/10.1371/journal.pone.0061735. 


Endorsed by

ISH logo
EAS logo
AEG logo
EPC logo
EMAS logo

ISGE logo